Amlodipine and Valsartan
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
23155-844 -
Package NDC
23155-844-03 -
Package NDC
23155-844-09 -
Application number
ANDA090011 -
SPL ID
a1e93c2f-051c-40b9-a0ba-bfcf78a9c2d4 -
SPL set ID
55a1d22e-04ad-4475-9b05-0d534e289160 -
UNII
1J444QC288 -
UNII
80M03YXJ7I -
RxCUI
722126 -
RxCUI
722131 -
RxCUI
722134 -
RxCUI
722137
What the source publishes
- Labeler
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- Active ingredients
- amlodipine and valsartan
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Amlodipine and Valsartan",
"splId": "a1e93c2f-051c-40b9-a0ba-bfcf78a9c2d4",
"labels": [
{
"setId": "55a1d22e-04ad-4475-9b05-0d534e289160",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=55a1d22e-04ad-4475-9b05-0d534e289160",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=55a1d22e-04ad-4475-9b05-0d534e289160"
}
],
"routes": [
"ORAL"
],
"labeler": "Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE, PLASTIC (23155-844-03)",
"package_ndc": "23155-844-03",
"identifierStatus": "well-formed",
"marketing_start_date": "20230315"
},
{
"sample": false,
"description": "90 TABLET in 1 BOTTLE, PLASTIC (23155-844-09)",
"package_ndc": "23155-844-09",
"identifierStatus": "well-formed",
"marketing_start_date": "20230315"
}
],
"productId": "23155-844_a1e93c2f-051c-40b9-a0ba-bfcf78a9c2d4",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "23155-844",
"deaSchedule": null,
"genericName": "amlodipine and valsartan",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "AMLODIPINE",
"strength": "5 mg/1"
},
{
"name": "VALSARTAN",
"strength": "160 mg/1"
}
],
"applicationNumber": "ANDA090011",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20230315",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000000069",
"N0000175421",
"N0000175566",
"M0006414",
"N0000190114",
"N0000000070",
"N0000175561"
],
"upc": [
"0323155847093",
"0323155845099",
"0323155846096"
],
"unii": [
"1J444QC288",
"80M03YXJ7I"
],
"rxcui": [
"722126",
"722131",
"722134",
"722137"
],
"spl_set_id": [
"55a1d22e-04ad-4475-9b05-0d534e289160"
],
"pharm_class_cs": [
"Dihydropyridines [CS]"
],
"pharm_class_epc": [
"Dihydropyridine Calcium Channel Blocker [EPC]",
"Calcium Channel Blocker [EPC]",
"Angiotensin 2 Receptor Blocker [EPC]"
],
"pharm_class_moa": [
"Calcium Channel Antagonists [MoA]",
"Cytochrome P450 3A Inhibitors [MoA]",
"Angiotensin 2 Receptor Antagonists [MoA]"
],
"manufacturer_name": [
"Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:23155-844_a1e93c2f-051c-40b9-a0ba-bfcf78a9c2d4"